Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Clinical Trial

Comparative Study

Review

Randomized Controlled Trial

Multicenter Study

Publication Year

From

Quick links

Individual year

2006

2005

2004

2002

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Rilmenidine""[mesh_terms]

7 Results

Searching titles within these results

Update on rilmenidine: clinical benefits.

J L Reid

American journal of hypertension 2002;14(11 Pt 2):322S-324S

Full Text

Abstract

Efficacy and safety of rilmenidine, a selective imidazoline I1 receptor binding ligand, in mild-to-moderate Thai hypertensive patients.

Peera Buranakitjaroen, Peerapong Kittipawong, Banhan Koanantakul, Chumpol Piamsomboon, Nattanun Prasassarakich, Songkwan Silaraks, Apichard Sukonthasarn, Assada Tiyapant

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2004;86(10):903-10

Full Text

Abstract

Rilmenidine--its antihypertensive efficacy, safety and impact on quality of life in perimenopausal women with mild to moderate essential hypertension.

Kalina Kawecka-Jaszcz, Danuta Czarnecka, Marek Klocek, Michał Zabojszcz, Marta Kucharska, Rafał Jaworski, Robert Pachocki

Blood pressure 2006;15(1):51-8

Free Full Text

Abstract

I1 receptors, cardiovascular function, and metabolism.

P Bousquet

American journal of hypertension 2002;14(11 Pt 2):317S-321S

Full Text

Abstract

Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.

Jana Sirotiaková, Jirí Widimský

Current medical research and opinion 2006;22(7):1287-94

Full Text

Abstract

Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.

Olga V Schastnaya, Nadezhda A Shostak, Dmitrii A Anichkov

Current medical research and opinion 2005;21(1):113-9

Full Text

Abstract

How can we block sympathetic overactivity? Effects of rilmenidine and atenolol in overweight hypertensive patients.

E V Shlyakhto, E V Smirnova, A N Krutikov, N V Vachrameeva, E K Shavarova, A A Shavarov, Y R Kasherininov, A O Konrady

Journal of human hypertension 2006;20(6):398-406

Full Text

Abstract

Results: 1 – 7 / 7

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Rilmenidine""[mesh_terms]

Update on rilmenidine: clinical benefits.

Efficacy and safety of rilmenidine, a selective imidazoline I1 receptor binding ligand, in mild-to-moderate Thai hypertensive patients.

Rilmenidine--its antihypertensive efficacy, safety and impact on quality of life in perimenopausal women with mild to moderate essential hypertension.

I1 receptors, cardiovascular function, and metabolism.

Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.

Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.

How can we block sympathetic overactivity? Effects of rilmenidine and atenolol in overweight hypertensive patients.

Results for
""Rilmenidine""[mesh_terms]